Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationEBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Barinthus Biotherapeutics (BRNS) Receivables - Net (2020 - 2023)

Barinthus Biotherapeutics (BRNS) has disclosed Receivables - Net for 4 consecutive years, with $172000.0 as the latest value for Q1 2023.

  • For Q1 2023, Receivables - Net fell 99.05% year-over-year to $172000.0; the TTM value through Mar 2023 reached $172000.0, down 99.05%, while the annual FY2022 figure was $5.5 million, 27400.0% up from the prior year.
  • Receivables - Net hit $172000.0 in Q1 2023 for Barinthus Biotherapeutics, down from $5.5 million in the prior quarter.
  • Across five years, Receivables - Net topped out at $18.0 million in Q1 2022 and bottomed at $20000.0 in Q4 2021.
  • Average Receivables - Net over 4 years is $2.7 million, with a median of $172000.0 recorded in 2023.
  • Year-over-year, Receivables - Net surged 27400.0% in 2022 and then tumbled 99.05% in 2023.
  • Barinthus Biotherapeutics' Receivables - Net stood at $518000.0 in 2020, then plummeted by 96.14% to $20000.0 in 2021, then soared by 27400.0% to $5.5 million in 2022, then plummeted by 96.87% to $172000.0 in 2023.
  • According to Business Quant data, Receivables - Net over the past three periods came in at $172000.0, $5.5 million, and $26000.0 for Q1 2023, Q4 2022, and Q3 2022 respectively.